Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Pneumococcal Pyopericardium With Xiphoid Osteomyelitis in HIV/AIDS: A Rare but Potentially Fatal Complication
Nihar Jena1, Izza Saeed1, Mackenzie Hamilton1
1Department of Interventional Cardiology, Marshall University, Huntington, West Virginia, USA.
Purulent pericarditis, a rare infection, can occur in immunocompromised patients. This case highlights successful management of pneumococcal pyopericardium with cardiac tamponade in an HIV patient.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Purulent pericarditis is a rare but life-threatening infection, increasingly seen in immunocompromised individuals.
- Antibiotic use has reduced its incidence, but opportunistic infections remain a risk.
- It often arises from secondary bacterial spread.
Observation:
- A 55-year-old man with HIV cardiomyopathy presented with chest pain and dyspnea.
- Initial cardiac catheterization showed normal coronary arteries, but echocardiography revealed pericardial effusion with tamponade.
- Pericardial fluid analysis identified Streptococcus pneumoniae.
Findings:
- The patient required pericardiocentesis and later a subxiphoid pericardial wash due to reaccumulating effusion.
- A concurrent diagnosis of acute osteomyelitis of the xiphoid was made.
- Treatment involved antibiotics and drainage procedures.
Implications:
- This case underscores the risk of opportunistic infections like pneumococcal pyopericardium in HIV patients, even with antiretroviral therapy.
- Prompt diagnosis and multidisciplinary management are crucial for improving outcomes in this rare condition.
- It highlights advancements in managing purulent pericarditis with tamponade.
More Related Videos
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
13:50Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumothorax-II
Clinical Manifestations:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: